Icp-248
Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Beijing InnoCare Pharma Tech Co., Ltd.Phase 2
—
Rating in progress
Icp-248 in Relapsed or Refractory Mantle Cell Lymphoma (MCL) is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active